Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Net Cash Flow (2022 - 2025)

Historic Net Cash Flow for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to $2.1 million.

  • 60 Degrees Pharmaceuticals' Net Cash Flow rose 2469.42% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $808516.0, marking a year-over-year decrease of 2115.74%. This contributed to the annual value of -$483631.0 for FY2024, which is 12663.51% down from last year.
  • 60 Degrees Pharmaceuticals' Net Cash Flow amounted to $2.1 million in Q3 2025, which was up 2469.42% from -$1.5 million recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' Net Cash Flow's 5-year high stood at $2.2 million during Q3 2023, with a 5-year trough of -$1.6 million in Q4 2024.
  • For the 4-year period, 60 Degrees Pharmaceuticals' Net Cash Flow averaged around $252392.5, with its median value being -$130230.0 (2023).
  • Per our database at Business Quant, 60 Degrees Pharmaceuticals' Net Cash Flow skyrocketed by 81657.11% in 2023 and then tumbled by 1240958.38% in 2024.
  • Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Net Cash Flow stood at -$193251.0 in 2022, then soared by 32.61% to -$130230.0 in 2023, then crashed by 1158.81% to -$1.6 million in 2024, then skyrocketed by 231.0% to $2.1 million in 2025.
  • Its Net Cash Flow stands at $2.1 million for Q3 2025, versus -$1.5 million for Q2 2025 and $1.8 million for Q1 2025.